Treatment of Anxiety and Depression in Transplant Patients: Pharmacokinetic Considerations

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.43, Iss.6, 2004-01, pp. : 361-394

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunosuppressive Therapy for Paediatric Transplant Patients: Pharmacokinetic Considerations

By Fernández de Gatta M.d.M.

Clinical Pharmacokinetics, Vol. 41, Iss. 2, 2002-01 ,pp. : 115-135

Adis International

Access to resources Recommend Favorite

Pharmacokinetic Considerations in the Treatment of Tuberculosis in Patients with Renal Failure

By Launay-Vacher Vincent Izzedine Hassane Deray Gilbert

Clinical Pharmacokinetics, Vol. 44, Iss. 3, 2005-01 ,pp. : 221-235

Adis International

Access to resources Recommend Favorite

Depression in Patients with Schizophrenia: Prevalence, and Diagnostic and Treatment Considerations

By Hausmann A.

CNS Drugs, Vol. 14, Iss. 4, 2000-10 ,pp. : 289-299

Adis International

Access to resources Recommend Favorite

Insomnia in Patients with Depression: Some Pathophysiological and Treatment Considerations

By Jindal Ripu D.

CNS Drugs, Vol. 23, Iss. 4, 2009-01 ,pp. : 309-329

Adis International

Access to resources Recommend Favorite

Pharmacokinetic considerations for the treatment of diabetes in patients with chronic kidney disease

By Scheen André J

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 5, 2013-05 ,pp. : 529-550

Informa Healthcare

Access to resources Recommend Favorite